AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PARADIGM BIOPHARMACEUTICALS-WS

0.075

0.000

Volume:- -

Turnover:8.64K

Market Cap:- -

PE:- -

High:0.075

Open:0.075

Low:0.075

Close:0.075

Loading ...

Overview Company News Filings

Company Profile

Company Name:

PARADIGM BIOPHARMACEUTICALS-WS

Exchange:

ASX

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.paradigmbiopharma.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable and tablet forms for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PAROA.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PAROA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PAROA.AU\",,,,,undefined,":{"symbol":"PAROA.AU","market":"AU","secType":"WAR","nameCN":"PARADIGM BIOPHARMACEUTICALS-WS","latestPrice":0.075,"timestamp":1749686471943,"preClose":0.075,"halted":0,"volume":0,"delay":0,"strike":0.65,"lastTradingDate":1770728400000,"nameEN":"PARADIGM BIOPHARMACEUTICALS-WS","floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"06-12 10:01:11 AEST","open":0.075,"high":0.075,"low":0.075,"amount":8637.264779308,"amplitude":0,"askPrice":0.09,"askSize":2875,"bidPrice":0.075,"bidSize":56492,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1749708000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.075,"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","type":1,"expireDate":1770728400000,"ul":"PAR.AU","ulStockBrief":{"symbol":"PAR.AU","market":"AU","secType":"STK","nameCN":"PARADIGM BIOPHARMACEUTICALS","latestPrice":0.3,"timestamp":1749686471946,"preClose":0.3,"halted":0,"volume":0,"delay":0}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PAROA.AU\",,,,,undefined,":{"symbol":"PAROA.AU","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0.075,"amplitude":0,"preClose":0.075,"low":0.075,"week52Low":0.06,"pbRate":"--","week52High":0.245,"institutionHeld":0,"latestPrice":0.075,"committee":0.903145,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.075,"prevYearClose":0.08,"prevWeekClose":0.091,"prevMonthClose":0.092,"prevQuarterClose":0.095,"fiveDayClose":0.09,"twentyDayClose":0.105,"sixtyDayClose":0.15},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.paradigmbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.1667},{"period":"1month","weight":-0.2188},{"period":"3month","weight":-0.4643},{"period":"6month","weight":-0.0625},{"period":"ytd","weight":-0.0625}],"compareEarnings":[{"period":"1week","weight":-0.0049},{"period":"1month","weight":0.0368},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1376},{"period":"1year","weight":0.191},{"period":"ytd","weight":0.1458}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable and tablet forms for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.","exchange":"ASX","name":"PARADIGM BIOPHARMACEUTICALS-WS","nameEN":"PARADIGM BIOPHARMACEUTICALS-WS"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PAROA.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PAROA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PAROA.AU\",market:\"AU\",,,undefined,":[]}}